Latest News & Features
Americas
Pharmaceutical companies AbbVie and Besins Healthcare have been ordered to pay the US Federal Trade Commission $448 million for using “sham litigation” to block access to generic versions of a testosterone drug. 2 July 2018
Americas
The US Court of Appeals for the Federal Circuit has ruled that a passing mention in the prior art of a formulation that references the claimed ingredient and administration may not be enough to invalidate a patent claim. 2 July 2018
Americas
Holland & Hart has added Loren Hulse as a partner to the firm’s Salt Lake City office. 2 July 2018
Europe
Private equity investor Advent International has agreed to acquire France-based Sanofi's European generics business Zentiva. 29 June 2018
Big Pharma
Mathys & Squire has added Peter Arch and Craig Titmus to the firm’s partnership. 29 June 2018
Big Pharma
Switzerland’s highest court held that new supplementary protection certificates for combination products should be governed by the relevant EU law, in a dispute over a Swiss SPC owned by Gilead Sciences. 28 June 2018
Americas
The US is leading the way in synthetic biology patent filings, according to a report released earlier this month from patent search software company PatSnap. 28 June 2018
Americas
AbbVie and Alphabet have committed a further $1 billion to fund Alphabet-backed Calico’s development of new therapies for patients with age-related diseases. 27 June 2018
Asia-Pacific
The Australian Competition and Consumer Commission said yesterday that it has sought to appeal against a decision by the Full Federal Court of Australia in a case involving Pfizer. 26 June 2018
Americas
The US Supreme Court has agreed to hear a dispute over whether confidential sales of an invention can trigger the on-sale bar and invalidate a patent under the America Invents Act. 26 June 2018